Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05024344 · ClinicalTrials.gov registry record · NA
ESP Block vs Control for Pain Control Following Percutaneous Nephrolithotomy
A NA study of Nephrolithotomy, Percutaneous, sponsored by University of Tennessee Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 128
- Enrollment target
- 1
- Study location
NCT05024344: Recruiting NA study of Nephrolithotomy, Percutaneous, sponsored by University of Tennessee Medical Center.
NCT05024344 is a NA study of Nephrolithotomy, Percutaneous that is actively recruiting participants, run by University of Tennessee Medical Center. The registered enrollment target is 128 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05024344, a NA study of Nephrolithotomy, Percutaneous, is actively recruiting participants, sponsored by University of Tennessee Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 128 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate the use of the erector spinae (ESP) block in reducing the morphine milligram equivalent (MME) consumption post percutaneous nephrolithotomy. Objectives: 1. \- Determine if there is a significant effect on post percutaneous nephrolithotomy MME consumption with the usage of an ESP block vs. saline control. 2. \- Determine if there is a significant effect on reported pain levels with the use of an ESP block vs. saline control in post percutaneous nephrolithotomies.
Primary Outcome
Opioid consumption (MME) in the first 24 hours postoperative
Conditions Studied
Interventions
- DRUG Dexamethasone
- PROCEDURE Erector Spinae Plane Block
- DRUG Ropivacaine 0.5% Injectable Solution
Study Locations (1)
Tennessee
- University of Tennessee Medical Center - Knoxville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2021-08-09 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT05024344 shows while recruiting
NCT05024344 is an interventional study that assigns participants to a tested intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Nephrolithotomy, Percutaneous appearing as the primary indexed condition, and to 3 interventions - of which Dexamethasone is the first listed.
NCT05024344 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT05024344 about?
NCT05024344 is a clinical study titled "ESP Block vs Control for Pain Control Following Percutaneous Nephrolithotomy". The purpose of this study is to investigate the use of the erector spinae (ESP) block in reducing the morphine milligram equivalent (MME) consumption post percutaneous nephrolithotomy. Objectives: 1. \- Determine if there is a significant effect on post percutaneous nephrolithotomy MME consumption ...
What is the current status of trial NCT05024344?
This trial is currently recruiting. It is a NA study. The enrollment target is 128 participants. The study started on 2021-08-09. Estimated completion is 2026-06-30.
What conditions does trial NCT05024344 study?
This clinical trial studies the following conditions: Nephrolithotomy, Percutaneous.
What interventions are being tested in trial NCT05024344?
The interventions under investigation include: Dexamethasone (DRUG), Erector Spinae Plane Block (PROCEDURE), Ropivacaine 0.5% Injectable Solution (DRUG).
Who is sponsoring clinical trial NCT05024344?
This trial is sponsored by University of Tennessee Medical Center, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05024344 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05024344's enrollment target sits among peer trials
128 744th of 2000 higher than 1,253 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02870738 · 128 participants · Phase 2
Bladder Directed vs. Pelvic Floor Therapy in IC/BPS
- NCT03294460 · 128 participants · Phase 1
Nicotinic Receptor Genetic Variation and Alcohol Reward
- NCT04149977 · 128 participants · NA
Blood Flow Restriction Therapy in Lower Limb Extensor Injuries
- NCT04373057 · 128 participants · Phase 1
Prebiotic Galacto-oligosaccharide and Acute GVHD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI